User profiles for Anna Smielewska
 | Anna SmielewskaConsultant Clinical Virologist, LUHFT Verified email at liverpoolft.nhs.uk Cited by 1584 |
[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK
…, S Woolley, A Chawla, I Hart, A Smielewska… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …
[HTML][HTML] Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
[HTML][HTML] Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
…, S Bloor, A Ogbe, WM Zelek, A Smielewska… - Nature …, 2020 - nature.com
The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting
JP Skittrall, M Wilson, AA Smielewska, S Parmar… - Clinical Microbiology …, 2021 - Elsevier
Objectives When the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is low, many positive test results are false positives. Confirmatory testing reduces …
is low, many positive test results are false positives. Confirmatory testing reduces …
[PDF][PDF] Point of care nucleic acid testing for SARS-CoV-2 in hospitalized patients: a clinical validation trial and implementation study
There is an urgent need for rapid SARS-CoV-2 testing in hospitals to limit nosocomial spread.
We report an evaluation of point of care (POC) nucleic acid amplification testing (NAAT) in …
We report an evaluation of point of care (POC) nucleic acid amplification testing (NAAT) in …
Complexity of intracranial pressure correlates with outcome after traumatic brain injury
CW Lu, M Czosnyka, JS Shieh, A Smielewska… - Brain, 2012 - academic.oup.com
This study applied multiscale entropy analysis to investigate the correlation between the
complexity of intracranial pressure waveform and outcome after traumatic brain injury. …
complexity of intracranial pressure waveform and outcome after traumatic brain injury. …
Preparing for the next pandemic: reserve laboratory staff are crucial
…, P Silverston, H Yang, SH Aliyu, AA Smielewska - bmj, 2022 - bmj.com
… Anna A Smielewska, consultant virologist8… Ann Acad Med Singap 2016;45:332-7. doi:10.47102/annals-acadmedsg.V45N8p332
pmid:27683737 … Articles by Anna A Smielewska …
pmid:27683737 … Articles by Anna A Smielewska …
[HTML][HTML] A Low Complexity Rapid Molecular Method for Detection of Clostridium difficile in Stool
…, JE Smythe, MJ Wigglesworth, A Smielewska… - PLoS …, 2014 - journals.plos.org
Here we describe a method for the detection of Clostridium difficile from stool using a novel
low-complexity and rapid extraction process called Heat Elution (HE). The HE method is two-…
low-complexity and rapid extraction process called Heat Elution (HE). The HE method is two-…
Streamlining SARS-CoV-2 confirmatory testing to reduce false positive results
MJ Wilson, D Sparkes, C Myers, AA Smielewska… - Journal of Clinical …, 2021 - Elsevier
Background Confirmatory testing of SARS-CoV-2 results is essential to reduce false positives,
but comes at a cost of significant extra workload for laboratories and increased turnaround …
but comes at a cost of significant extra workload for laboratories and increased turnaround …
In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir
Background Human parainfluenza type 3 (HPIV3) is an important respiratory pathogen.
Although a number of potential therapeutic candidates exist, there is currently no licensed …
Although a number of potential therapeutic candidates exist, there is currently no licensed …
